• 9731 Citations
  • 38 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Outputs

Filter
Article
2015

Positive lifestyle changes following urological cancer diagnoses: an Australian interview based study

Cerimagic, S., Ahmadi, N., Gurney, H., Hossack, T. & Patel, M. I., 1 Jun 2015, In : International Journal of Human Rights in Healthcare. 8, 2, p. 110-119 10 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2014

Accelerated BEP for metastatic germ cell tumours: A multicenter phase II trial by the Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

Grimison, P. S., Stockler, M. R., Chatfield, M., Thomson, D. B., Gebski, V., Friedlander, M., Boland, A. L., Houghton, B., Gurney, H., Rosenthal, M., Singhal, N., Kichenadasse, G., Wong, S. S., Lewis, C. R., Vasey, P. A. & Toner, G. C., Jan 2014, In : Annals of Oncology. 25, 1, p. 143-148 6 p., mdt369.

Research output: Contribution to journalArticle

20 Citations (Scopus)

Association analysis of genetic polymorphisms in genes related to sunitinib pharmacokinetics, specifically clearance of sunitinib and SU12662

Diekstra, M. H. M., Klümpen, H. J., Lolkema, M. P. J. K., Yu, H., Kloth, J. S. L., Gelderblom, H., Van Schaik, R. H. N., Gurney, H., Swen, J. J., Huitema, A. D. R., Steeghs, N. & Mathijssen, R. H. J., Jul 2014, In : Clinical Pharmacology and Therapeutics. 96, 1, p. 81-89 9 p.

Research output: Contribution to journalArticle

52 Citations (Scopus)

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer

Lin, H. M., Castillo, L., Mahon, K. L., Chiam, K., Lee, B. Y., Nguyen, Q., Boyer, M. J., Stockler, M. R., Pavlakis, N., Marx, G., Mallesara, G., Gurney, H., Clark, S. J., Swarbrick, A., Daly, R. J. & Horvath, L. G., 13 May 2014, In : British Journal of Cancer. 110, 10, p. 2462-2471 10 p.

Research output: Contribution to journalArticle

81 Citations (Scopus)

Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer

Mahon, K. L., Qu, W., Devaney, J., Paul, C., Castillo, L., Wykes, R. J., Chatfield, M. D., Boyer, M. J., Stockler, M. R., Marx, G., Gurney, H., Mallesara, G., Molloy, P. L., Horvath, L. G. & Clark, S. J., 28 Oct 2014, In : British Journal of Cancer. 111, 9, p. 1802-1809 8 p.

Research output: Contribution to journalArticle

Open Access
File
44 Citations (Scopus)
3 Downloads (Pure)

Predictive value of CYP3A and ABCB1 phenotyping probes for the pharmacokinetics of sunitinib: The ClearSun study

Kloth, J. S. L., Klümpen, H. J., Yu, H., Eechoute, K., Samer, C. F., Kam, B. L. R., Huitema, A. D. R., Daali, Y., Zwinderman, A. H., Balakrishnar, B., Bennink, R. J., Wong, M., Schellens, J. H. M., Mathijssen, R. H. J. & Gurney, H., Mar 2014, In : Clinical Pharmacokinetics. 53, 3, p. 261-269 9 p.

Research output: Contribution to journalArticle

16 Citations (Scopus)
2013

Functional analysis of novel polymorphisms in the human SLCO1A2 gene that encodes the transporter OATP1A2

Zhou, F., Zheng, J., Zhu, L., Jodal, A., Cui, P. H., Wong, M., Gurney, H., Church, W. B. & Murray, M., 2013, In : AAPS Journal. 15, 4, p. 1099-1108 10 p.

Research output: Contribution to journalArticle

30 Citations (Scopus)

Impact of baseline and nadir neutrophil index in non-small cell lung cancer and ovarian cancer patients: Assessment of chemotherapy for resolution of unfavourable neutrophilia

Carus, A., Gurney, H., Gebski, V., Harnett, P., Hui, R., Kefford, R., Wilcken, N., Ladekarl, M., von der Maase, H. & Donskov, F., 2013, In : Journal of Translational Medicine. 11, p. 189 1 p.

Research output: Contribution to journalArticle

22 Citations (Scopus)

Primary treatment of the prostate improves local palliation in men who ultimately develop castrate-resistant prostate cancer

Won, A. C. M., Gurney, H., Marx, G., De Souza, P. & Patel, M. I., Aug 2013, In : BJU international. 112, 4, p. E250-E255 6 p.

Research output: Contribution to journalArticle

69 Citations (Scopus)

The prevalence and correlates of supportive care needs in testicular cancer survivors: A cross-sectional study

Smith, A., King, M., Butow, P., Luckett, T., Grimison, P., Toner, G. C., Stockler, M., Hovey, E., Stubbs, J., Hruby, G., Gurney, H., Turner, S., Alam, M., Cox, K. & Olver, I., Nov 2013, In : Psycho-Oncology. 22, 11, p. 2557-2564 8 p.

Research output: Contribution to journalArticle

37 Citations (Scopus)
2011

Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

Lee, C. K., Gurney, H., Brown, C., Sorio, R., Donadello, N., Tulunay, G., Meier, W., Bacon, M., Maenpaa, J., Petru, E., Reed, N., Gebski, V., Pujade-Lauraine, E., Lord, S., Simes, R. J. & Friedlander, M., 26 Jul 2011, In : British Journal of Cancer. 105, 3, p. 360-365 6 p.

Research output: Contribution to journalArticle

21 Citations (Scopus)

Environmental and genetic factors affecting transport of imatinib by OATP1A2

Eechoute, K., Franke, R. M., Loos, W. J., Scherkenbach, L. A., Boere, I., Verweij, J., Gurney, H., Kim, R. B., Tirona, R. G., Mathijssen, R. H. J. & Sparreboom, A., 2011, In : Clinical Pharmacology and Therapeutics. 89, 6, p. 816-820 5 p.

Research output: Contribution to journalArticle

41 Citations (Scopus)

Paraneoplastic hepatic dysfunction in metastatic prostate cancer: the role of cytokine dysregulation

Nguyen, V., Gurney, H. & Van Der Poorten, D., 10 Jan 2011, In : Journal of Clinical Oncology. 29, 2, p. 1-3 3 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)
2010

Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: Updated analysis of a randomized trial

Grimison, P. S., Stockler, M. R., Thomson, D. B., Olver, I. N., Harvey, V. J., Gebski, V. J., Lewis, C. R., Levi, J. A., Boyer, M. J., Gurney, H., Craft, P., Boland, A. L., Simes, R. J. & Toner, G. C., 18 Aug 2010, In : Journal of the National Cancer Institute. 102, 16, p. 1253-1262 10 p.

Research output: Contribution to journalArticle

45 Citations (Scopus)

Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy

Nath, C. E., Shaw, P. J., Trotman, J., Zeng, L., Duffull, S. B., Hegarty, G., McLachlan, A. J., Gurney, H., Kerridge, I., Kwan, Y. L., Presgrave, P., Tiley, C., Joshua, D. & Earl, J., May 2010, In : British Journal of Clinical Pharmacology. 69, 5, p. 484-497 14 p.

Research output: Contribution to journalArticle

45 Citations (Scopus)
2009

An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancer

Pezaro, C., Rosenthal, M. A., Gurney, H., Davis, I. D., Underhill, C., Boyer, M. J., Kotasek, D., Solomon, B. & Toner, G. C., Aug 2009, In : American Journal of Clinical Oncology: Cancer Clinical Trials. 32, 4, p. 338-341 4 p.

Research output: Contribution to journalArticle

40 Citations (Scopus)
2008

Improving outcomes for operable pancreatic cancer: is access to safer surgery the problem?

Chang, D. K., Merrett, N. D., Biankin, A. V. & NSW Pancreatic Cancer Network, Jul 2008, In : Journal of Gastroenterology and Hepatology (Australia). 23, 7 Pt 1, p. 1036-45 10 p.

Research output: Contribution to journalArticle

23 Citations (Scopus)
13 Citations (Scopus)

Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand

Bell, D., Grimes, D., Gurney, H., Dalley, D., Blackwell, T., Fox, R. & Jeffery, M., Oct 2008, In : Internal Medicine Journal. 38, 10, p. 751-757 7 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)
2007

Imatinib disposition and ABCB1 (MDR1, P-glycoprotein) genotype

Gurney, H., Wong, M., Balleine, R. L., Rivory, L. P., McLachlan, A. J., Hoskins, J. M., Wilcken, N., Clarke, C. L., Mann, G. J., Collins, M., Delforce, S. E., Lynch, K. & Schran, H., 14 Jul 2007, In : Clinical Pharmacology and Therapeutics. 82, 1, p. 33-40 8 p.

Research output: Contribution to journalArticle

116 Citations (Scopus)
2006

Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer

Spry, N. A., Kristjanson, L., Hooton, B., Hayden, L., Neerhut, G., Gurney, H., Corica, T., Korbel, E., Weinstein, S. & McCaul, K., May 2006, In : European Journal of Cancer. 42, 8, p. 1083-1092 10 p.

Research output: Contribution to journalArticle

92 Citations (Scopus)

Maintaining bone health in patients with prostate cancer

Holmes-Walker, J., Woo, H., Gurney, H., Do, V. T. & Chipps, D. R., 20 Feb 2006, In : Medical Journal of Australia. 184, 4, p. 176-179 4 p.

Research output: Contribution to journalArticle

22 Citations (Scopus)

Predictors of vinorelbine pharmacokinetics and pharmacodynamics in patients with cancer

Wong, M., Balleine, R. L., Blair, E. Y. L., McLachlan, A. J., Ackland, S. P., Garg, M. B., Evans, S., Farlow, D., Collins, M., Rivory, L. P., Hoskins, J. M., Mann, G. J., Clarke, C. L. & Gurney, H., 1 Jun 2006, In : Journal of Clinical Oncology. 24, 16, p. 2448-2455 8 p.

Research output: Contribution to journalArticle

50 Citations (Scopus)
2005

Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer

Wong, M., Evans, S., Rivory, L. P., Hoskins, J. M., Mann, G. J., Farlow, D., Clarke, C. L., Balleine, R. L. & Gurney, H., Jan 2005, In : Clinical Pharmacology and Therapeutics. 77, 1, p. 33-42 10 p.

Research output: Contribution to journalArticle

56 Citations (Scopus)
2004

CYP3A5 genotype and midazolam clearance in Australian patients receiving chemotherapy

Wong, M., Balleine, R. L., Collins, M., Liddle, C., Clarke, C. L. & Gurney, H., Jun 2004, In : Clinical Pharmacology and Therapeutics. 75, 6, p. 529-538 10 p.

Research output: Contribution to journalArticle

77 Citations (Scopus)
2002

How to calculate the dose of chemotherapy

Gurney, H., 22 Apr 2002, In : British Journal of Cancer. 86, 8, p. 1297-1302 6 p.

Research output: Contribution to journalArticle

160 Citations (Scopus)

Phase II trial of branched peginterferon-α 2a (40 kDa) for patients with advanced renal cell carcinoma

Motzer, R. J., Rakhit, A., Thompson, J., Gurney, H., Selby, P., Figlin, R., Negrier, S., Ernst, S., Siebels, M., Ginsberg, M., Rittweger, K. & Hooftman, L., 1 Nov 2002, In : Annals of Oncology. 13, 11, p. 1799-1805 7 p.

Research output: Contribution to journalArticle

47 Citations (Scopus)

α-interferon 2a and 13-cis-retinoic acid for the treatment of metastatic renal cell carcinoma

Wong, M., Goldstein, D., Woo, H., Testa, G. & Gurney, H., 2002, In : Internal Medicine Journal. 32, 4, p. 158-162 5 p.

Research output: Contribution to journalArticle

6 Citations (Scopus)
2001

Carboplatin and gemcitabine in metastatic transitional cell carcinoma of the urothelium: Effective treatment of patients with poor prognostic features

Shannon, C., Crombie, C., Brooks, A., Lau, H., Drummond, M. & Gurney, H., 2001, In : Annals of Oncology. 12, 7, p. 947-952 6 p.

Research output: Contribution to journalArticle

45 Citations (Scopus)
2000

A phase II trial of paclitaxel and epirubicin in advanced breast cancer

Rischin, D., Smith, J., Millward, M., Lewis, C., Boyer, M., Richardson, G., Toner, G., Gurney, H. & McKendrick, J., 2000, In : British Journal of Cancer. 83, 4, p. 438-442 5 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Home or hospital? An evaluation of the costs, preferences, and outcomes of domiciliary chemotherapy

King, M. T., Hall, J., Caleo, S., Gurney, H. P. & Harnett, P. R., 2000, In : International Journal of Health Services. 30, 3, p. 557-579 23 p.

Research output: Contribution to journalArticle

35 Citations (Scopus)
1999

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer

Bishop, J. F., Dewar, J., Toner, G. C., Smith, J., Tattersall, M. H. N., Olver, I. N., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J., Stephenson, J. & Canetta, R., Aug 1999, In : Journal of Clinical Oncology. 17, 8, p. 2355-2364 10 p.

Research output: Contribution to journalArticle

187 Citations (Scopus)

Long-term follow-up of patients treated with intermittent hormone therapy for advanced prostate cancer

Hruby, G., Gurney, H., Turner, S., Berry, M., Harnett, P. & Gebski, V., May 1999, In : Prostate Journal. 1, 3, p. 138-143 6 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)
1998

Factors affecting epirubicin pharmacokinetics and toxicity: Evidence against using body-surface area for dose calculation

Gurney, H. P., Ackland, S., Gebski, V. & Farrell, G., Jul 1998, In : Journal of Clinical Oncology. 16, 7, p. 2299-2304 6 p.

Research output: Contribution to journalArticle

100 Citations (Scopus)
7 Citations (Scopus)

Skull metastases masquerading as cerebral secondaries in patients with cancer

Wright, J., Gurney, H. & Glare, P., 1998, In : Australian and New Zealand Journal of Medicine. 28, 1, p. 62 1 p.

Research output: Contribution to journalArticle

1997

A randomized study of paclitaxel versus cyclophosphamide/methotrexate/- fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results

Bishop, J. F., Dewar, J., Toner, G., Tattersall, M. H., Olver, I., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J. & Stephenson, J., 1997, In : Seminars in Oncology. 24, 5 SUPPL. 17, p. S17-5-S17-9 5 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Paclitaxel as first-line treatment for metastatic breast cancer

Bishop, J. F., Dewar, J., Toner, G. C., Tattersall, M. H., Olver, I. N., Ackland, S., Kennedy, I., Goldstein, D., Gurney, H., Walpole, E., Levi, J. & Stephenson, J., 1997, In : ONCOLOGY. 11, 4 SUPPL. 3, p. 19-23 5 p.

Research output: Contribution to journalArticle

19 Citations (Scopus)
1995

Continuous infusion of vincristine, ifosfamide and epirubicin over 6 weeks in treatment-resistant advanced breast cancer

Gurney, H., Harnett, P., Stuart-Harris, R. & Kefford, R., 1995, In : European Journal of Cancer. 31, 11, p. 1773-1777 5 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
1993

A cost-utility approach to the use of 5-fluorouracil and levamisole ad adjuvant chemotherapy for Dukes' C colonic carcinoma

Smith, R. D., Hall, J., Gurney, H. & Harnett, P. R., 1993, In : Medical Journal of Australia. 158, 5, p. 319-320 2 p.

Research output: Contribution to journalArticle

35 Citations (Scopus)

Hypercalcaemia in small cell lung cancer: Report of a case associated with parathyroid hormone-related protein (PTHrP)

Stuart-Harris, R., Ahern, V., Danks, J. A., Gurney, H. & Martin, T. J., 1993, In : European Journal of Cancer. 29, 11, p. 1601-1604 4 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Parathyroid hormone-related protein and response to pamidronate in tumour-induced hypercalcaemia

Gurney, H., Grill, V. & Martin, T. J., 26 Jun 1993, In : The Lancet. 341, 8861, p. 1611-1613 3 p.

Research output: Contribution to journalArticle

92 Citations (Scopus)
1992

Granulocyte colony-stimulating factor to prevent dose-limiting neutropenia in non-Hodgkin's lymphoma: a randomized controlled trial

Pettengell, R., Gurney, H., Radford, J. A., Deakin, D. P., James, R., Wilkinson, P. M., Kane, K., Bentley, J. & Crowther, D., 1992, In : Blood. 80, 6, p. 1430-1436 7 p.

Research output: Contribution to journalArticle

377 Citations (Scopus)

Haemopoietic cell kinetics in humans treated with rGM‐CSF

Lord, B. I., Gurney, H., Chang, J., Thatcher, N., Crowther, D. & Dexter, T. M., 1992, In : International Journal of Cancer. 50, 1, p. 26-31 6 p.

Research output: Contribution to journalArticle

62 Citations (Scopus)

Infection risk in patients with small cell lung cancer receiving intensive chemotherapy and recombinant human granulocyte-macrophage colony-stimulating factor

Gurney, H., Anderson, H., Radford, J., Potter, M. R., Swindell, R., Steward, W., Kamthan, A., Chang, J., Weiner, J., Thatcher, N. & Crowther, D., 1992, In : European Journal of Cancer. 28, 1, p. 105-112 8 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)
1991

A phase II study of ifosfamide and a2b-interferon in advanced non-small-cell lung cancer

Lind, M. J., Gomm, S., Simmonds, A. P., Ashcroft, L., Kamthan, A., Gurney, H. & Thatcher, N., Mar 1991, In : Cancer Chemotherapy and Pharmacology. 28, 2, p. 142-144 3 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)

Ifosfamide and mitomycin in combination for the treatment of patients with progressive advanced non-small cell lung cancer

Gurney, H., de Campos, E. S., Dodwell, D., Kamthan, A. & Thatcher, N., 1991, In : European Journal of Cancer and Clinical Oncology. 27, 5, p. 565-567 3 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)

The use of L-dopa and carbidopa in metastatic malignant melanoma

Gurney, H., Coates, A. & Kefford, R., Jan 1991, In : Journal of Investigative Dermatology. 96, 1, p. 85-87 3 p.

Research output: Contribution to journalArticle

20 Citations (Scopus)
1990

Five year follow-up and dose delivery analysis of cisplatin, iproplatin or carboplatin in combination with cyclophosphamide in advanced ovarian carcinoma

Gurney, H., Crowther, D., Anderson, H., Murphy, D., Prendiville, J., Ranson, M., Mayor, P., Swindell, R., Buckley, C. H. & Tindall, V. R., Nov 1990, In : Annals of Oncology. 1, 6, p. 427-433 7 p.

Research output: Contribution to journalArticle

47 Citations (Scopus)

The management of primary fallopian tube carcinoma

Gurney, H., Murphy, D. & Crowther, D., 1990, In : British Journal of Obstetrics and Gynaecology. 97, 9, p. 822-826 5 p.

Research output: Contribution to journalArticle

25 Citations (Scopus)